Department of Clinical Laboratory, Anqing Municipal Hospital, Anqing 246003, China.
Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China; Institute of Microsurgery on Extremities, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Int J Infect Dis. 2021 Mar;104:601-609. doi: 10.1016/j.ijid.2021.01.045. Epub 2021 Jan 27.
Overt and occult hepatitis B infection (HBI) among mothers and infants were investigated, and the effectiveness of vaccination against HBI was evaluated based on transmission types.
A hospital-based cohort was built with 2,734 mothers and 330 mother-infant pairs. Their demographic data were collected. Serological HBV markers, nested-PCR for HBV genes, viral load detection, and phylogenetic analysis were done.
The overall prevalence of HBI among mothers was 12.1% (330/2,734), with 10.4% for the overt type and 1.8% for the occult type. In 330 out of 1,650 (20%) mother-infant pairs, the overall, type-I (from overt mother to overt infant), type-II (from overt mother to occult infant), and type-Ⅲ (from occult mother to occult infant) transmissions were 1.9% (1/54), 5.6% (3/54) and 0.0% (0/7). The refinement of HBI classification improved the estimate of vaccine effectiveness against HBI from 74.4%-80.9% to 94.4%, which was more prominent for type-II. One mother-infant pair with type-II transmission shared nearly identical complete sequences. However, the high rate of lost-to-follow-up could not be ignored.
During the transition period, HBV is mainly transmitted from the overt type of HBI mother to infant. Intensive prenatal screening for mothers is vital.
调查母亲和婴儿的显性和隐匿性乙型肝炎病毒(HBV)感染情况,并根据传播类型评估乙型肝炎病毒免疫预防的效果。
采用医院为基础的队列研究方法,纳入 2734 名母亲和 330 对母婴,收集其人口统计学数据。进行血清 HBV 标志物检测、HBV 基因巢式 PCR、病毒载量检测和系统进化分析。
母亲 HBI 的总体患病率为 12.1%(330/2734),显性型为 10.4%,隐匿型为 1.8%。在 1650 对母婴中,330 对母婴(20%)中存在总体、I 型(从显性母亲到显性婴儿)、II 型(从显性母亲到隐匿性婴儿)和 III 型(从隐匿性母亲到隐匿性婴儿)传播,传播率分别为 1.9%(1/54)、5.6%(3/54)和 0.0%(0/7)。细化 HBI 分类后,乙型肝炎病毒免疫预防对 HBI 的估计效果从 74.4%至 80.9%提高到 94.4%,对 II 型的效果更为显著。1 对具有 II 型传播的母婴共享了几乎完全相同的完整序列。然而,失访率过高不容忽视。
在过渡时期,HBV 主要由显性 HBI 母亲传播给婴儿。对母亲进行强化产前筛查至关重要。